11 results
8-K
EX-99.1
MGTX
MeiraGTx Holdings plc
14 Mar 24
MeiraGTx Reports Fourth Quarter and Full Year 2023 Financial and Operational Results and Recent Business Updates
9:16am
in vivo has been quite remarkable. We look forward to presenting this data in an R&D day later this year. In the area of metabolic disease, we have … technology platform at an R&D day in the second half of 2024.
Asset Purchase Agreement with Jannsen:
On December 20, 2023, MeiraGTx entered
8-K
EX-99.1
MGTX
MeiraGTx Holdings plc
10 Mar 22
MeiraGTx Reports Fourth Quarter and Full Year 2021 Financial and Operational Results
8:15am
Radiation-Induced Xerostomia Announced
- First In Vivo Data from Riboswitch Gene Regulation Platform at R&D Day Presented
LONDON and NEW YORK, March 10
8-K
EX-99.1
fyw7fg1 rjtxab40z3
11 Aug 21
MeiraGTx Reports Second Quarter 2021 Financial and Operational Results
8:11am
8-K
EX-99.1
8gfeijj
11 May 21
MeiraGTx Reports First Quarter 2021 Financial and Operational Results
8:13am
- Prev
- 1
- Next